Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Change in Cash (2020 - 2025)

BioAtla (BCAB) has disclosed Change in Cash for 6 consecutive years, with -$1.2 million as the latest value for Q4 2025.

  • For Q4 2025, Change in Cash rose 83.91% year-over-year to -$1.2 million; the TTM value through Dec 2025 reached -$41.9 million, up 32.83%, while the annual FY2025 figure was -$41.9 million, 32.83% up from the prior year.
  • Change in Cash hit -$1.2 million in Q4 2025 for BioAtla, up from -$9.9 million in the prior quarter.
  • Across five years, Change in Cash topped out at $62.3 million in Q3 2021 and bottomed at -$30.8 million in Q1 2024.
  • Average Change in Cash over 5 years is -$11.6 million, with a median of -$17.3 million recorded in 2021.
  • Year-over-year, Change in Cash crashed 7206.45% in 2021 and then skyrocketed 249.87% in 2022.
  • BioAtla's Change in Cash stood at -$24.9 million in 2021, then surged by 249.87% to $37.4 million in 2022, then tumbled by 179.74% to -$29.8 million in 2023, then surged by 74.94% to -$7.5 million in 2024, then skyrocketed by 83.91% to -$1.2 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$1.2 million, -$9.9 million, and -$14.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.